Medical guideline

首页肿瘤学指南检索结果

检索结果

按发表年份

共搜索到69条与Recommendation有关的结果

The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：其他 | 腹膜肿瘤

Japan Society of Gynecologic Oncology

The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely (1) Overview of the Guidelines (2) Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Recurrent Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (4) Borderline Epithelial Tumors of the Ovary (5) Malignant Germ Cell Tumors of the Ovary and (6) Malignant Sex Cord-stromal Tumors. Furthermore the Guidelines Comprise 5 Algorithms-namely (1) Initial Treatment for Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (2) Treatment for Recurrent Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Initial Treatment for Borderline Epithelial Ovarian Tumor (4) Treatment for Malignant Germ Cell Tumor and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer" (2) Involvement of Patients and General (male/female) Participants in Addition to Physicians Pharmacists and Nurses (3) Clinical Questions (CQs) in the PICO Format (4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System (5) Introduction of the Idea of a Body of Evidence (6) Categorization of References According to Research Design (7) Performance of Systematic Reviews and Meta-analysis for Three CQs and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：其他 | 腹膜肿瘤

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
Surgical Management of Oncologic Patient During and after the COVID-19 Outbreak: Practical Recommendations from the Italian Society of Surgical Oncology

2021年发布于 Updates Surg 73卷第1期 所属人体系统：其他 | 治疗方案

Italian Society of Surgical Oncology

COVID-19 Cancer Oncologic Surgery Recommendations
指南简介 原文链接
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：生殖 | 输卵管癌

Japan Society of Gynecologic Oncology

The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely (1) Overview of the Guidelines (2) Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Recurrent Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (4) Borderline Epithelial Tumors of the Ovary (5) Malignant Germ Cell Tumors of the Ovary and (6) Malignant Sex Cord-stromal Tumors. Furthermore the Guidelines Comprise 5 Algorithms-namely (1) Initial Treatment for Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (2) Treatment for Recurrent Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Initial Treatment for Borderline Epithelial Ovarian Tumor (4) Treatment for Malignant Germ Cell Tumor and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer" (2) Involvement of Patients and General (male/female) Participants in Addition to Physicians Pharmacists and Nurses (3) Clinical Questions (CQs) in the PICO Format (4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System (5) Introduction of the Idea of a Body of Evidence (6) Categorization of References According to Research Design (7) Performance of Systematic Reviews and Meta-analysis for Three CQs and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 输卵管癌

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：生殖 | 卵巢肿瘤

Japan Society of Gynecologic Oncology

The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely (1) Overview of the Guidelines (2) Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Recurrent Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (4) Borderline Epithelial Tumors of the Ovary (5) Malignant Germ Cell Tumors of the Ovary and (6) Malignant Sex Cord-stromal Tumors. Furthermore the Guidelines Comprise 5 Algorithms-namely (1) Initial Treatment for Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (2) Treatment for Recurrent Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Initial Treatment for Borderline Epithelial Ovarian Tumor (4) Treatment for Malignant Germ Cell Tumor and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer" (2) Involvement of Patients and General (male/female) Participants in Addition to Physicians Pharmacists and Nurses (3) Clinical Questions (CQs) in the PICO Format (4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System (5) Introduction of the Idea of a Body of Evidence (6) Categorization of References According to Research Design (7) Performance of Systematic Reviews and Meta-analysis for Three CQs and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 卵巢肿瘤

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
Taiwan Nutritional Consensus on the Nutrition Management for Gastric Cancer Patients Receiving Gastrectomy

2021年发布于 Journal of the Formosan Medical Association 120卷第(1 Pt 1)期 所属人体系统：消化 | 胃癌

Gastroenterological Society of Taiwan

Gastrectomy Guidelines National Recommendations Nutritional Support
指南简介 原文链接
Recommendations on the Pathological Report of Pituitary Tumors. a Consensus of Experts of the Spanish Society of Endocrinology and Nutrition and the Spanish Society of Pathology

2021年发布于 Endocrinologia Diabetes Y Nutricion 68卷第3期 所属人体系统：内分泌 | 垂体肿瘤

Spanish Society of Endocrinology and Nutrition Spanish Society of Pathology

Anatomía Patológica Expert Recommendations Immunohistochemistry Inmunohistoquímica Neuroendocrine Tumors Pathology Recomendaciones De Expertos Tumores Neuroendocrinos
指南简介 原文链接
Special Considerations in the Management of Adult Patients with Acute Leukaemias and Myeloid Neoplasms in the COVID-19 Era: Recommendations from a Panel of International Experts

2020年发布于 Lancet Haematol 7卷第8期 所属人体系统：循环 | 骨髓瘤

无

Acute Leukaemias Myeloid Neoplasms Management COVID-19 Recommendations
指南简介 原文链接
ESMO Management and Treatment Adapted Recommendations in the COVID-19 Era: Breast Cancer

2020年发布于 ESMO Open 5卷第Suppl 3期 所属人体系统：生殖 | 乳腺肿瘤

European Society for Medical Oncology

COVID-19 ESMO Adapted Recommendations Breast Cancer.
指南简介 原文链接
ECO-SEOM-SEEO Safety Recommendations Guideline for Cancer Patients Receiving Intravenous Therapy

2020年发布于 Clinical and Translational Oncology 22卷第11期 所属人体系统：其他 | 治疗方案

Excellence and Quality in Oncology Spanish Society of Medical Oncology Spanish Society of Oncology Nursing

Cancer Therapy Clinical Practice Survey Decision Algorithm Evidence-based Recommendations Safety Venous Access.
指南简介 原文链接
Special Considerations in the Management of Adult Patients with Acute Leukaemias and Myeloid Neoplasms in the COVID-19 Era: Recommendations from a Panel of International Experts

2020年发布于 Lancet Haematol 7卷第8期 所属人体系统：循环 | 白血病

无

Acute Leukaemias Myeloid Neoplasms Management COVID-19 Recommendations
指南简介 原文链接
Acute Myeloid Leukaemia in Adult Patients: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up

2020年发布于 Ann Oncol 31卷第6期 所属人体系统：循环 | 白血病

European Society for Medical Oncology

European LeukaemiaNet World Health Organization Acute Myeloid Leukaemia Dosing Information Guideline Treatment Recommendation.
指南简介 原文链接
Management of Cardiac Disease in Cancer Patients Throughout Oncological Treatment: ESMO Consensus Recommendations

2020年发布于 Annals of Oncology 31卷第2期 所属人体系统：其他 | 癌症患者其他类问题管理

European Society for Medical Oncology

Clinical Practice Guidelines Cardiac Disease Cardiovascular Toxicity Diagnosis Recommendations.
指南简介 原文链接
Treatment of Advanced Non-small-cell Lung Cancer: the 2019 AIOM (Italian Association of Medical Oncology) Clinical Practice Guidelines

2020年发布于 Crit Rev Oncol Hematol 146卷第期 所属人体系统：呼吸 | 肺癌

Italian Association of Medical Oncology

Clinical Practice Guidelines Metastatic Disease Non-small Cell Lung Cancer Recommendations.
指南简介 原文链接
Interdisciplinary S2k Guidelines on the Diagnosis and Treatment of Uterine Sarcomas-recommendations for Surgical Pathology

2020年发布于 Pathologe 41卷第6期 所属人体系统：生殖 | 子宫肿瘤

无

Histopathology Prognosis Recommendations Staging Uterine Sarcomas WHO Workup.
指南简介 原文链接
Diagnosis and Treatment of Early and Locally Advanced Non-small-cell Lung Cancer: the 2019 AIOM (Italian Association of Medical Oncology) Clinical Practice Guidelines

2020年发布于 Crit Rev Oncol Hematol 148卷第期 所属人体系统：呼吸 | 肺癌

Italian Association of Medical Oncology

Clinical Practice Guidelines Early Disease Locally Advanced Disease Non-small Cell Lung Cancer Recommendations.
指南简介 原文链接
How to Capture Cytogenetic and Molecular Abnormalities Into ProMISe Database for Hematological Malignancies: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

2020年发布于 Bull Cancer 107卷第1S期 所属人体系统：循环 | 血液肿瘤

Francophone Society of Bone Marrow Transplantation and Cellular Therapy

Biologie Moléculaire Cytogenetics Cytogénétique Entering ProMISe Molecular Biology Recommandations SFGM-TC SFGM-TC Recommendations Saisie Sur ProMISe.
指南简介 原文链接
Radiation Treatment of Hemato-oncological Patients in Times of the COVID-19 Pandemic : Expert Recommendations from the Radiation Oncology Panels of the German Hodgkin Study Group and the German Lymphoma Alliance

2020年发布于 Strahlenther Onkol 196卷第12期 所属人体系统：循环 | 血液肿瘤

Radiation Oncology Panels of the German Hodgkin Study Group German Lymphoma Alliance

COVID SARS-CoV-2 Hematology Lymphoma Recommendation.
指南简介 原文链接

人体系统

共搜索到69条 与Recommendation有关的结果

2021年 发布于 Journal of Gynecologic Oncology 32卷 第2期 所属人体系统： 其他 | 腹膜肿瘤

Japan Society of Gynecologic Oncology

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 其他 | 腹膜肿瘤

Ontario Health (Cancer Care Ontario)

2021年 发布于 Updates Surg 73卷 第1期 所属人体系统： 其他 | 治疗方案

Italian Society of Surgical Oncology

2021年 发布于 Journal of Gynecologic Oncology 32卷 第2期 所属人体系统： 生殖 | 输卵管癌

Japan Society of Gynecologic Oncology

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 生殖 | 输卵管癌

Ontario Health (Cancer Care Ontario)

2021年 发布于 Journal of Gynecologic Oncology 32卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

Japan Society of Gynecologic Oncology

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

Ontario Health (Cancer Care Ontario)

2021年 发布于 Journal of the Formosan Medical Association 120卷 第(1 Pt 1)期 所属人体系统： 消化 | 胃癌

Gastroenterological Society of Taiwan

2021年 发布于 Endocrinologia Diabetes Y Nutricion 68卷 第3期 所属人体系统： 内分泌 | 垂体肿瘤

Spanish Society of Endocrinology and Nutrition Spanish Society of Pathology

2020年 发布于 Lancet Haematol 7卷 第8期 所属人体系统： 循环 | 骨髓瘤

无

2020年 发布于 ESMO Open 5卷 第Suppl 3期 所属人体系统： 生殖 | 乳腺肿瘤

European Society for Medical Oncology

2020年 发布于 Clinical and Translational Oncology 22卷 第11期 所属人体系统： 其他 | 治疗方案

Excellence and Quality in Oncology Spanish Society of Medical Oncology Spanish Society of Oncology Nursing

2020年 发布于 Lancet Haematol 7卷 第8期 所属人体系统： 循环 | 白血病

无

2020年 发布于 Ann Oncol 31卷 第6期 所属人体系统： 循环 | 白血病

European Society for Medical Oncology

2020年 发布于 Annals of Oncology 31卷 第2期 所属人体系统： 其他 | 癌症患者其他类问题管理

European Society for Medical Oncology

2020年 发布于 Crit Rev Oncol Hematol 146卷 第期 所属人体系统： 呼吸 | 肺癌

Italian Association of Medical Oncology

2020年 发布于 Pathologe 41卷 第6期 所属人体系统： 生殖 | 子宫肿瘤

无

2020年 发布于 Crit Rev Oncol Hematol 148卷 第期 所属人体系统： 呼吸 | 肺癌

Italian Association of Medical Oncology

2020年 发布于 Bull Cancer 107卷 第1S期 所属人体系统： 循环 | 血液肿瘤

Francophone Society of Bone Marrow Transplantation and Cellular Therapy

2020年 发布于 Strahlenther Onkol 196卷 第12期 所属人体系统： 循环 | 血液肿瘤

Radiation Oncology Panels of the German Hodgkin Study Group German Lymphoma Alliance

共搜索到69条与Recommendation有关的结果

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：其他 | 腹膜肿瘤

2021年发布于 Current Oncology 28卷第2期 所属人体系统：其他 | 腹膜肿瘤

2021年发布于 Updates Surg 73卷第1期 所属人体系统：其他 | 治疗方案

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：生殖 | 输卵管癌

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 输卵管癌

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：生殖 | 卵巢肿瘤

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 卵巢肿瘤

2021年发布于 Journal of the Formosan Medical Association 120卷第(1 Pt 1)期 所属人体系统：消化 | 胃癌

2021年发布于 Endocrinologia Diabetes Y Nutricion 68卷第3期 所属人体系统：内分泌 | 垂体肿瘤

2020年发布于 Lancet Haematol 7卷第8期 所属人体系统：循环 | 骨髓瘤

2020年发布于 ESMO Open 5卷第Suppl 3期 所属人体系统：生殖 | 乳腺肿瘤

2020年发布于 Clinical and Translational Oncology 22卷第11期 所属人体系统：其他 | 治疗方案

2020年发布于 Lancet Haematol 7卷第8期 所属人体系统：循环 | 白血病

2020年发布于 Ann Oncol 31卷第6期 所属人体系统：循环 | 白血病

2020年发布于 Annals of Oncology 31卷第2期 所属人体系统：其他 | 癌症患者其他类问题管理

2020年发布于 Crit Rev Oncol Hematol 146卷第期 所属人体系统：呼吸 | 肺癌

2020年发布于 Pathologe 41卷第6期 所属人体系统：生殖 | 子宫肿瘤

2020年发布于 Crit Rev Oncol Hematol 148卷第期 所属人体系统：呼吸 | 肺癌

2020年发布于 Bull Cancer 107卷第1S期 所属人体系统：循环 | 血液肿瘤

2020年发布于 Strahlenther Onkol 196卷第12期 所属人体系统：循环 | 血液肿瘤